Plain-English translation of NCT06658782 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a new type of MRI scan—one that takes only about 20 minutes and doesn't require any dye injection—might be better at catching early liver cancer in people at high risk. Right now, people with cirrhosis (scarring of the liver) get ultrasound scans every 6 months to look for cancer, but these scans sometimes miss tumors. The researchers want to see if the new MRI scan can find cancers that ultrasound might miss.
Many people with liver cirrhosis develop liver cancer, and early detection saves lives. However, standard ultrasound isn't perfect—it misses some cancers even when done regularly. The CT and MRI scans that are better at detecting cancer can't be done every 6 months because they're expensive, use radiation, or involve dye that can build up in the body over time. This new type of MRI without dye could offer a better option that's safe, quick, and affordable enough to use for regular screening.
You likely qualify if…
You likely don't qualify if…
You will continue to receive your regular ultrasound scans every 6 months as usual. In addition, you will have a research MRI scan—without any dye injection—at the same 6-month intervals. The MRI takes about 20 minutes and is non-invasive. The study compares what both scans find to see whether the MRI catches cancers that the ultrasound might have missed.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United Kingdom